Medicine is changing as technology advances and blockchain might be one of the next big steps. Paul Mampilly has been watching the bitcoin craze take place over the last few years. While he doesn’t put much faith in the cryptocurrency itself, he is interested in blockchain technology that is used for it.
Paul Mampilly has a good feel for the market and has worked with corporations and even members of royal families to help them make financial decisions. While he may technically be retired from the financial industry, he is still hard at work giving advice to others about the next big thing. He publishes a newsletter through Banyan Hill Publishing Company called Profits Unlimited that provides advice and stock analysis to his many readers.
As the S&P 500 hits a record and the Dow industrials comes very close to its all-time high, one market watcher has been tracking the bears vs. S&P battle. It’s been a lopsided affair — just take a look at this chart. https://t.co/Bi0zIk29Lh#SP500 #DowIndustrials #StockMarket pic.twitter.com/A6uVEY5VQR
— Paul Mampilly (@MampillyGuru) September 5, 2018
Lately, one of the big things that he has been discussing is the many different potential applications that he sees blockchain being potentially used for. When it comes to medicine, Paul Mampilly sees blockchain enabled pills being the wave of the future. It can be difficult for doctors to get a good idea of how effective the medication their patients are taking is. It’s usually done through the collection and analysis of blood and other bodily fluid samples and imaging.
With blockchain enabled pills that include sensors to measure chemicals in the bloodstream, doctors and patients will be able to track the effectiveness of their medication without ever leaving their house. Paul Mampilly understands that many people may not think these goals are realistic, but points out that Abilify is already implementing similar technology to track if the medication has been taken or not.
While measuring the effectiveness is important, tracking if the patient is taking the medication as instructed is also important. Many patients tend to forget their medication or take too much. By using similar methods as Abilify, doctors will be able to see if the problems with effectiveness are from the dosage or the patient not taking them properly.
It’s important to get into these types of investments early says Paul Mampilly. There is an enormous potential for growth and there are some companies available to invest in already. More information can be found by reading the Profits Unlimited newsletter.
Visit More : www.stockgumshoe.com/tag/paul-mampilly/